About: EGFR mutations in patients with advanced NSCLC.     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Genetic testing for the presence of activating EGFR mutations is an essential part of diagnosis of NSCLC and the results have a major impact on the choice of optimal cancer treatment. Molecular targeted therapy with tyrozine kinase inhibitors that block the activation cascade of epidermal growth factor receptor (EGFR-TKI), is one of the new modalities of treatment of NSCLC with advanced stage. In our study, analysis of patients survival with EGFR-TKI treatment showed significantly better profit from this therapy in patients carrying activating mutations of EGFR. The incidence of activating mutations of EGFR gene in NSCLC in our population and also their increased frequency in patients with adenocarcinoma, women and non-smokers correlated with published data in the literature.
  • Genetic testing for the presence of activating EGFR mutations is an essential part of diagnosis of NSCLC and the results have a major impact on the choice of optimal cancer treatment. Molecular targeted therapy with tyrozine kinase inhibitors that block the activation cascade of epidermal growth factor receptor (EGFR-TKI), is one of the new modalities of treatment of NSCLC with advanced stage. In our study, analysis of patients survival with EGFR-TKI treatment showed significantly better profit from this therapy in patients carrying activating mutations of EGFR. The incidence of activating mutations of EGFR gene in NSCLC in our population and also their increased frequency in patients with adenocarcinoma, women and non-smokers correlated with published data in the literature. (en)
Title
  • EGFR mutations in patients with advanced NSCLC.
  • EGFR mutations in patients with advanced NSCLC. (en)
skos:prefLabel
  • EGFR mutations in patients with advanced NSCLC.
  • EGFR mutations in patients with advanced NSCLC. (en)
skos:notation
  • RIV/26475821:_____/12:#0000136!RIV12-MZ0-26475821
http://linked.open...avai/predkladatel
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(NS9718)
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 133590
http://linked.open...ai/riv/idVysledku
  • RIV/26475821:_____/12:#0000136
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • NSCLC; EGFR mutations; advanced stage (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...ontrolniKodProRIV
  • [DB3A38D6C01E]
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...iv/tvurceVysledku
  • Benšová, Lucie
  • Minárik, Marek
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software